Effect of Nano Biphasic Calcium Phosphate Bioceramics on Periodontal Regeneration in the Treatment of Alveolar Defects

2012 ◽  
Vol 486 ◽  
pp. 422-425 ◽  
Author(s):  
Lan Lei Wang ◽  
Ji Hua Li ◽  
Yong Tao Xie ◽  
Pi Shan Yang ◽  
Yun Mao Liao ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Biphasic Calcium Phosphate ◽  
Alveolar Bone ◽  
Periodontal Regeneration ◽  
Bone Defects ◽  
Beagle Dogs ◽  
Control Groups ◽  
Negative Controls ◽  
Osseous Defects ◽  
Positive Controls

The aim of the present study is to investigate the efficacy of nanobiphasic calcium phosphate (nanoBCP) bioceramic in the treatment of periodontal osseous defects. Alveolar bone defects were surgically created bilaterally at the buccal aspects of four second premolars in two beagle dogs. After root leveling, nanoBCP was randomly filled in one defect and nothing was put into the contralateral defect as negative controls. Bioglass was randomly filled in one of left defect as positive controls and nothing was put into the contralateral defect as negative controls. Dogs were killed at the 12th week. Histological observations were processed through a light microscopy. The results reveal that a great amount of functional periodontal fissures formed in the defects in the nanoBCP groups and bioglass groups while no new bone formed in the control groups at all. In this study, nanoBCP has proven to work well as a biocompatible and bioactive material to promote periodontal regeneration effectively.

Assessing the Effect of Nano Biphasic Calcium Phosphate on Acute Alveolar Bone Defects in Beagle Dogs Using Micro-Computed Tomography Imaging

2012 ◽  
Vol 465 ◽  
pp. 132-135 ◽  
Author(s):  
Lan Lei Wang ◽  
He Ying Hou ◽  
Jian Xin Zhang ◽  
Zong Mei Sun ◽  
Pi Shan Yang ◽  
...  
Keyword(s):  
Calcium Phosphate ◽  
Biphasic Calcium Phosphate ◽  
Alveolar Bone ◽  
Bone Defects ◽  
Acute Type ◽  
Beagle Dogs ◽  
Micro Computed Tomography ◽  
Computed Tomography Imaging ◽  
Tomography Imaging ◽  
Computed Tomographic

The aim of the present study was to assess the effect of nano-biphasic calcium phosphate (nanoBCP) scaffolds on acute alveolar bone defects in beagle dogs by micro-computed tomographic imaging (μCT). Alveolar bone defects were surgically created bilaterally at the buccal aspects of the upper second premolars in four beagle dogs. After root conditioning with ethylenediaminetetraacetate (EDTA), nanoBCP was randomly filled in the defects and nothing was put into the contralateral defects as controls. Dogs were killed at the 24th weeks. Specimens were scanned and reconstructed though μCT. The results revealed that much new alveolar bone formed in the defects in the nanoBCP groups while no new alveolar bone formed in the controls. The present results indicate that PBCP may enhance alveolar bone regeneration in acute-type labial dehiscence defects.

scholarly journals Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Yao Yao ◽  
Frederic Kauffmann ◽  
Shogo Maekawa ◽  
Lea V. Sarment ◽  
James V. Sugai ◽  
...  
Keyword(s):  
Targeted Drug Delivery ◽  
Low Dose ◽  
Alveolar Bone ◽  
Tumor Resection ◽  
Periodontal Regeneration ◽  
Neutralizing Antibody ◽  
Bone Defects ◽  
Dose Delivery ◽  
Osseous Defects ◽  
Sclerostin Antibody

Abstract Destruction of the alveolar bone in the jaws can occur due to periodontitis, trauma or following tumor resection. Common reconstructive therapy can include the use of bone grafts with limited predictability and efficacy. Romosozumab, approved by the FDA in 2019, is a humanized sclerostin-neutralizing antibody (Scl-Ab) indicated in postmenopausal women with osteoporosis at high risk for fracture. Preclinical models show that Scl-Ab administration preserves bone volume during periodontal disease, repairs bone defects surrounding dental implants, and reverses alveolar bone loss following extraction socket remodeling. To date, there are no studies evaluating Scl-Ab to repair osseous defects around teeth or to identify the efficacy of locally-delivered Scl-Ab for targeted drug delivery. In this investigation, the use of systemically-delivered versus low dose locally-delivered Scl-Ab via poly(lactic-co-glycolic) acid (PLGA) microspheres (MSs) was compared at experimentally-created alveolar bone defects in rats. Systemic Scl-Ab administration improved bone regeneration and tended to increase cementogenesis measured by histology and microcomputed tomography, while Scl-Ab delivered by MSs did not result in enhancements in bone or cemental repair compared to MSs alone or control. In conclusion, systemic administration of Scl-Ab promotes bone and cemental regeneration while local, low dose delivery did not heal periodontal osseous defects in this study.

Positive Osteocalcin Expressions in Periodontium Regenerated by Nano Bioceramics after Orthodontic Tooth Movement

2022 ◽  
Vol 905 ◽  
pp. 277-281
Author(s):  
Lan Lei Wang ◽  
Jian Xin Zhang ◽  
Yuan Li ◽  
Sai Nan Zhao
Keyword(s):  
Alveolar Bone ◽  
Tooth Movement ◽  
Orthodontic Tooth Movement ◽  
Bone Defects ◽  
Normal Function ◽  
Beagle Dogs ◽  
Control Groups ◽  
The Third ◽  
Graft Choice ◽  
Orthodontic Forces

The research is to analyse the immunohistochemical reaction of orthodontic force on the periodontium reformed by nanobiphasic calcium phosphate ceramics (nBCP). Two third incisors were selected randomly and operated as experimental groups in 2 Beagle dogs. In the labial aspects of the third incisors, alveolar bone defects were surgically made and implanted with NBCP. The contralateral teeth in the same jaw did not receive any treatment as control. After 24 weeks, all the third incisors were moved labially. The dogs were euthanized 4 weeks later. The expression levels of osteocalcin were detected by immunohistochemical staining. Positive osteocalcin expressions in regenerated periodontium were observed and compared with the normal periodontium in the control groups. There were no significant differences within and between them. It means the periodontium regenerated by nBCP can bear orthodontic forces with a normal function. Based on these findings, we concluded that nBCP may offer a new bone graft choice for periodontic disease patients who have demands for orthodontic treatment.

scholarly journals A Combination of Biphasic Calcium Phosphate (Maxresorb®) and Hyaluronic Acid Gel (Hyadent®) for Repairing Osseous Defects in a Rat Model

2020 ◽  
Vol 10 (5) ◽  
pp. 1651 ◽  
Author(s):  
Abeer G. Ahmed ◽  
Fatin A. Awartani ◽  
Abdurahman A. Niazy ◽  
John A. Jansen ◽  
Hamdan S. Alghamdi
Keyword(s):  
Hyaluronic Acid ◽  
Calcium Phosphate ◽  
Bone Regeneration ◽  
Rat Model ◽  
Biphasic Calcium Phosphate ◽  
Bone Defects ◽  
Group I ◽  
Male Wistar Rats ◽  
Osseous Defects

The aim of this in vivo study was to evaluate the efficacy of biphasic calcium phosphate (Maxresorb®, BCP) used in combination with hyaluronic acid (Hyadent®, HyA) gel for regeneration of osseous defects in a rat model. Bilateral femoral condylar bone defects (3 mm diameter and 3 mm depth) were created in 40 male Wistar rats. The defects were grafted as group I (BCP only), group II (BCP + HyA), group III (HyA only), and group IV (empty control). At four weeks and 10 weeks, the bone specimens were evaluated using histological and histomorphometrical analyses to identify the newly formed bone area (NF-BA (%)), as well as the remaining BCP particles (R-BCP (%)). Light microscopic examination indicated the absence of an inflammatory reaction within the bone defects after four weeks or 10 weeks of implantation. Significant new bone regeneration was present in the bone defects grafted with BCP or BCP + HyA biomaterials, as early as four weeks, compared to control groups. The addition of HyA to BCP did not significantly improve bone regeneration at four weeks or 10 weeks. Nevertheless, its role in bone healing and regeneration warrants further investigation.

Fabrication of Biphasic Calcium Phosphate Foam Granular and its Initial Evaluation Using Beagle Dogs

2008 ◽  
Vol 396-398 ◽  
pp. 233-236
Author(s):  
Ishikawa Kunio ◽  
Ryouji Shimogoryo ◽  
Hanae Wakae ◽  
Akari Takeuchi ◽  
Shigeki Matsuya
Keyword(s):  
Calcium Phosphate ◽  
Bone Formation ◽  
Biphasic Calcium Phosphate ◽  
Blood Clot ◽  
Formation Rate ◽  
Bone Defects ◽  
Carbonate Apatite ◽  
Beagle Dogs ◽  
Bone Formation Rate ◽  
Reconstruction Rate

Biphasic calcium phosphate foam consisting of core aTCP covered with carbonate apatite (CO3Ap) was fabricated based on the compositional transformation by exposing aTCP foam to (NH4)2HPO4 aqueous solution at 200 °C for 90min in order to understand the effect on bone formation rate and granule remaining ratio. The BCP foam was gently crushed and sieved to prepare foam granular. Bone defects made at the mandible of beagle dog were reconstructed with aTCP, BCP and CO3Ap foam granular. 3 months after surgery, bone reconstruction rate of the BCP and CO3Ap were 159.7±28.6% and 169.0±29.7% whereas those of aTCP and blood clot group were 89.5±14.7% and 85.2±13.2%, respectively, and no further increase was observed at 6 month. On the other hand, granular remaining ratio was 3.0±1.7%, 3.1±1.8%, 6.9±2.0% for BCP, aTCP and CO3Ap foam granular, respectivly. We concluded therefore, BCP foam granular could be an ideal bone substitute since it alllows large porosity, at least similar bone formation ratio to CO3Ap and faster replacement to bone.

scholarly journals Bone Loss around Dental Implants 5 Years after Implantation of Biphasic Calcium Phosphate (HAp/βTCP) Granules

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Vadims Klimecs ◽  
Alexanders Grishulonoks ◽  
Ilze Salma ◽  
Laura Neimane ◽  
Janis Locs ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Calcium Phosphate ◽  
Bone Loss ◽  
Dental Implants ◽  
Biphasic Calcium Phosphate ◽  
Alveolar Bone ◽  
Clinical Situation ◽  
Cone Beam ◽  
Calcium Phosphate Ceramic ◽  
Middle Point

Biphasic calcium phosphate ceramic granules (0.5–1.0 mm) with a hydroxyapatite and β-tricalcium phosphate ratio of 90/10 were used. Biphasic calcium phosphate ceramic granules produced in the Riga Technical University, Riga Rudolph Cimdins Biomaterials Innovation and Development Centre, were used for filling the bone loss on 18 patients with peri-implantitis. After 5 years at the minimum, clinical and 3D cone-beam computed tomography control was done. Clinical situation confirmed good stability of implants without any signs of inflammation around. Radiodensity of the previous gap and alveolar bone horizontally from middle point of dental implants showed similar radiodensity as in normal alveolar bone. This trial is registered with ISRCTN13514478.

Sign in / Sign up

Export Citation Format

Share Document